Colleen F. Reitan - Jun 3, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Nathan A. Smith For: Colleen F. Reitan
Stock symbol
MYGN
Transactions as of
Jun 3, 2021
Transactions value $
$0
Form type
4
Date filed
6/4/2021, 07:43 PM
Next filing
Jul 19, 2021
SEC
View on sec.gov

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests on the anniversary of the date of grant.